Maziar Mike Doustdar, President and CEO at Novo Nordisk, shared on LinkedIn:
“Today, Novo Nordisk is expanding its collaboration with Amazon Web Services (AWS).
As our preferred cloud provider and strategic AI partner, we will explore how AI can help our scientists, engineers and teams solve complex problems faster and bring new ideas closer to patients.
I’m especially excited about our co-innovation hub in London, where colleagues from Novo Nordisk and AWS will work side by side.
I believe this kind of close collaboration is where real progress happens.
AI will not replace the scientific expertise, judgement and curiosity of our people.
But used responsibly, it can help us move faster and focus where it matters most: discovering, developing and delivering better medicines for people living with serious chronic diseases.
I am looking forward to seeing what our teams create together.”
Other articles about Novo Nordisk on OncoDaily.